Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia

Blood Research

Volumn 48, Issue 2, 2013, Pages 154-156

  Hashino, Satoshi ^a   Takahashi, Shojiro ^a   Morita, Rena ^a   Kanamori, Hiroe ^a   Onozawa, Masahiro ^a   Kawamura, Takahito ^a   Kahata, Kaoru ^a   Kondo, Takeshi ^a   Tokimatsu, Issei ^b   Sugita, Takashi ^c   Akizawa, Koji ^d   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; RANIMUSTINE; RITUXIMAB; VINCRISTINE SULFATE; VORICONAZOLE;

ADULT; BLOOD ANALYSIS; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FUNGEMIA; HUMAN; LETTER; TRICHOSPORON; TRICHOSPORON DERMATIS;

EID: 84884257222     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2013.48.2.154     Document Type: Letter

References (12)

1. Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 2009;49:e11-7.
2. Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005;43:1818-28.
3. Sugita T, Takashima M, Nakase T, Ichikawa T, Ikeda R, Shinoda T. Two new yeasts, Trichosporon debeurmannianum sp. nov. and Trichosporon dermatis sp. nov., transferred from the Cryptococcus humicola complex. Int J Syst Evol Microbiol 2001;51: 1221-8.
4. Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002;40:1826-30.
5. Ahmad S, Al-Mahmeed M, Khan ZU. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 2005;54:639-46.
6. Sugita T, Ikeda R, Nishikawa A. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol 2004;42:5467-71.
7. Gunn SR, Reveles XT, Hamlington JD, Sadkowski LC, Johnson-Pais TL, Jorgensen JH. Use of DNA sequencing analysis to confirm fungemia due to Trichosporon dermatis in a pediatric patient. J Clin Microbiol 2006;44:1175-7.
8. Fekkar A, Brun S, D'Ussel M, et al. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis 2009;49:1457-8.
9. Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009;47:1074-81.
10. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005;49:4026-34.
11. Trifilio S, Pennick G, Pi J, et al. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer 2007;109: 1532-5.
12. Vazquez JA. Trichosporon infection. Curr Fungal Infect Rep 2010;4:52-8.